Lipoprotein Lipase (LPL) (Middle Region) Peptide
Aperçu rapide pour Lipoprotein Lipase (LPL) (Middle Region) Peptide (ABIN8104527)
Antigène
Origine
Source
Application
-
-
Protein Region
- Middle Region
-
Fonction
- LPL Peptide - middle region
-
Séquence
- YESWVPKLVA ALYKREPDSN VIVVDWLSRA QEHYPVSAGY TKLVGQDVAR
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
This is a synthetic peptide designed for use in combination with anti- LPL Antibody (ARP97751_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- Lipoprotein Lipase (LPL)
-
Sujet
-
Background Information: LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism.
Alternative Symbols: LIPD, HDLCQ11
-
Poids moléculaire
- 52 kDa
-
ID gène
- 4023
-
NCBI Accession
- NP_000228
-
UniProt
- P06858
Antigène
-